MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) reported record annual revenue for 2024, but profit was still elusive for the multistate operator. But the multistate cannabis operator has its eye on the upcoming Delaware adult-use market to provide a boost.
MariMed’s full-year revenue reached $158 million, up from $148.6 million in 2023….
Please login to read all 424 words.
